NaguehSFSmisethOAAppletonCP, et al.Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J – Cardiovascular Imaging2016; 17: 1321–1360.
2.
KuznetsovaTHerbotsLLopezB, et al.Prevalence of left ventricular diastolic dysfunction in a general population. Circ Heart Fail2009; 2: 105–112.
3.
PonikowskiPVoorsAAAnkerSD, et al.2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J2016; 37: 2129–2200.
4.
PalauPNunezEDomingezE, et al.Physical therapy in heart failure with preserved ejection fraction: a systematic review. Eur J Prev Cardiol2016; 23: 4–13.
5.
FischerMBaesslerAHenseHW, et al.Prevalence of left ventricular diastolic dysfunction in the community: results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J2003; 24: 320–328.
6.
KlapholzMMaurerMLoweAM, et al.New York Heart Failure Consortium. Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry. J Am Coll Cardiol2004; 43: 1432–1438.
7.
FerrariR. the PREAMI Investigators. Effects of angiotensin converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study. Arch Intern Med2006; 166: 659–666.
8.
GoharAKievitRFValstarGB, et al.Opportunistic screening models for high-risk men and women to detect diastolic dysfunction and heart failure with preserved ejection fraction in the community. Eur J Prev Cardiol2018; 26: 613–623.
9.
Van RietEESHoesAWLimburgA, et al.Prevalence of unrecognized heart failure in older persons with shortness of breath on exertion. Eur J Heart Fail2014; 16: 772–777.
10.
Van MourikYBertensLCMCramerMJM, et al.Unrecognized heart failure and chronic obstructive pulmonary disease (COPD) in frail elderly detected through a near-home targeted screening strategy. J Am Board Fam Med2014; 27: 811–821.
11.
RuttenFHCramerM-JMGrobbeeDE, et al.Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J2005; 26: 1887–1894.
12.
Boonman-de WinterLJMRuttenFHCramerMJ, et al.Early recognition of heart failure in patients with diabetes type 2 in primary care. A prospective diagnostic efficiency study (UHFO-DM2). BMC Public Health2009; 9: 479–479.
13.
KievitRFGoharAHoesAW, et al.Efficient selective screening for heart failure in elderly men and women from the community: a diagnostic individual participant data meta-analysis on behalf of the Queen of hearts and RECONNECT consortium. Eur J Prev Cardiol2018; 25: 437–446.
14.
NelsonMDWeiJMerzNB. Coronary microvascular dysfunction and heart failure with preserved ejection fraction as female-pattern cardiovascular disease: the chicken or the egg?Eur Heart J2018; 39: 850–852.
15.
BleuminkGSKnetschAMSturkenboomMCJM, et al.Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure the Rotterdam study. Eur Heart J Engl2004; 25: 1614–1619.
16.
OwanTEHodgeDOHergesRM, et al.Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med2006; 355: 251–259.
17.
VasanRSXanthakisVLyassA, et al.Epidemiology of left ventricular systolic dysfunction and heart failure in the Framingham study: an echocardiographic study over 3 decades. JACC Cardiovasc Imaging2018; 11: 1–11.
18.
BhatiaRSTuJVLeeDS, et al.Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med2006; 355: 260–269.
19.
ReddyYNVCarterREObokataM, et al.A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction. Circulation2018; 138: 861–870.
20.
PaulusWJ. H2FPEF Score. At last, a properly validated diagnostic algorithm for heart failure with preserved ejection fraction. Circulation2018; 138: 871–873.
21.
AnjanVYLoftusTMBurkeMA, et al.Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction. Am J Cardiol2012; 110: 870–876.
22.
CaballeroLKouSDulgheruR, et al.Echocardiographic reference ranges for normal cardiac Doppler data: results from the NORRE Study. Eur Heart J Cardiovasc Imaging2015; 16: 1031–1041.
23.
LangRMBadanoLPMor-AviV, et al.Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr2015; 28: 1–39.
24.
KempsHKränkelNDörrM, et al.Exercise training for patients with type 2 diabetes and cardiovascular disease: what to pursue and how to do it. A Position Paper of the European Association of Preventive Cardiology (EAPC). Eur J Prev Cardiol2019; 26: 709–727.
25.
Kraigher-KrainerEShahAMGuptaDK, et al.Impaired systolic function by strain imaging in heart failure with preserved ejection fraction. J Am Coll Cardiol2014; 63: 447–456.
26.
WangJKhouryDSYueY, et al.Preserved left ventricular twist and circumferential deformation, but depressed longitudinal and radial deformation in patients with diastolic heart failure. Eur Heart J2008; 29: 1283–1289.
27.
MorrisDAMaXBelyavskiyE, et al.Left ventricular longitudinal systolic function analysed by 2D speckle tracking echocardiography in heart failure with preserved ejection fraction: a meta-analysis. Open Heart2017; 4: e000630–e000630.
28.
KurtMWangJTorre-AmioneG, et al.Left atrial function in diastolic heart failure. Circ Cardiovasc Imaging2009; 2: 10–15.
29.
NappoRDegiovanniABolzaniV, et al.Quantitative assessment of atrial conduit function: a new index of diastolic dysfunction. Clin Res Cardiol2016; 105: 17–28.
30.
ČelutkienėJPlymenCMFlachskampfFA, et al.Innovative imaging methods in heart failure: a shifting paradigm in cardiac assessment. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail2018; 20: 1615–1633.
31.
LedwidgeMGallagherJConlonC, et al.Natriuretic peptide-based screening and collaborative care for heart failure. JAMA2013; 310: 66–74.
32.
ParikhKSSharmaKFiuzatM, et al.Heart failure with preserved ejection fraction expert panel report current controversies and implications for clinical trials. J Am Coll Cardiol2018; 6: 619–632.
33.
TellesFMarwickTH. Imaging and management of heart failure and preserved ejection fraction. Curr Treat Options Cardio Med2018; 20: 90–90.
34.
TsujimotoTKajioH. Efficacy of renin–angiotensin system inhibitors for patients with heart failure with preserved ejection fraction and mild to moderate chronic kidney disease. Eur J Prev Cardiol2018; 25: 1268–1277.
35.
LamCSPVoorsAAde BoerRA, et al.Heart failure with preserved ejection fraction: from mechanisms to therapies. Eur Heart J2018; 39: 2780–2792.
